Clinical Trial Update: Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and Adolescents [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the clinical usability of nasal glucagon for treating hypoglycemia in children and adolescents has been completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Hypoglycemia

Drugs mentioned

• Nasal Glucagon (glucagon)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypoglycemia, Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2017-06-26